{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-084200","form_type":"8-K","ticker":"APLS","cik":"0001492422","company_name":"Apellis Pharmaceuticals, Inc.","filed_at":"2022-03-25T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.704317+00:00","generated_at":"2026-06-26T17:16:45.608495+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Apellis prices public offering of 7.4M shares at $47/sh, raising $350M gross","bullets":["7,446,809 shares at $47.00 per share; gross proceeds of $350 million.","Net proceeds estimated at $330.2 million ($379.8 million if underwriters' option fully exercised).","Offering expected to close March 28, 2022; underwriters have 30-day option for 1,117,021 additional shares.","J.P. Morgan, Goldman Sachs, and Evercore acting as joint book-running managers."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-084200","json":"https://secwatch.observer/filing/0001193125-22-084200.json","markdown":"https://secwatch.observer/filing/0001193125-22-084200.md","text":"https://secwatch.observer/filing/0001193125-22-084200.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1492422/000119312522084200/0001193125-22-084200-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1492422/000119312522084200/d268112d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T17:16:45.608495+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}